LAS VEGAS, Feb. 21 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals
Inc., (OTC Bulletin Board: SPHC) will host its Annual Meeting of shareholders
at 10 a.m. on Friday, June 27, 2003 at the Sterling Club, Turnberry Towers,
2827 Paradise Rd., Las Vegas, Nevada.
(Photo: http://www.newscom.com/cgi-bin/prnh/20030129/SPHCLOGO )
Also, Scientists from Samaritan Research Labs, Georgetown University will
make a presentation "Targeting Innovative Therapies to Treat and Prevent
Memory Loss and Alzheimer's."
About Samaritan Pharmaceuticals
Samaritan Pharmaceuticals, in collaboration with Georgetown University,
strives to commercialize breakthrough scientific innovation. Samaritan is
primarily focused on the development of innovative therapies for Alzheimer's,
Cancer, Cholesterol Reduction and HIV. Samaritan's patented pipeline closest
to commercialization includes: a completed HIV Phase II trial with positive
significant data; an Animal (rat) model used to test Alzheimer's drugs; an
Alzheimer's and Breast Cancer Diagnostic; a Peptide that binds cholesterol;
and a series of innovative neuroprotective compounds.
Disclaimer
The company disclaims any information that is created by an outside party
and endorses only information that is communicated by its press releases,
filings and Web site. This news release contains forward-looking statements
that reflect management's current beliefs about the potential for its drug
candidates, science and technology. However, as with any biopharmaceutical
under development, there are significant risks and uncertainties in the
process of development and regulatory review. There are no guarantees that
products will prove to be commercially successful. For additional information
about the factors that affect the company's business, please read the
company's latest Form 10-K filed April 26, 2002. The company undertakes no
duty to update forward-looking statements.
Contact: Samaritan Pharmaceuticals, Inc.,
702/735-7001, Fax 702/737-7016
Gene Boyle, Business Development, Email GeneBoyle@aol.com Doug
Bessert, Investor Relations, Email DougBessert@aol.com
To receive future press releases and newsletters automatically,
or for more information, visit our Web site at
http://www.samaritanpharmaceuticals.com.
SOURCE Samaritan Pharmaceuticals, Inc.
 back to top
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20030129/SPHCLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840
Related links:
http://www.samaritanpharmaceuticals.com
Company News On-Call:
http://www.prnewswire.com/gh/cnoc/comp/158311.html
CONTACT:
Gene Boyle, Business Development,
GeneBoyle@aol.com, or Doug Bessert, Investor Relations,
DougBessert@aol.com, both of Samaritan Pharmaceuticals, Inc.,
+1-702-735-7001, or fax, +1-702-737-7016
|
